We're alive during a store-brand renaissance, and name brands are ... According to the market-research firm IRI, private-label products are often 20% cheaper on average than brand-name products, but they're also much cheaper for retailers to buy, making way for higher profit margins. The issue for companies like Cetaphil's maker, Galderma, is that their sales are tied to being on the shelves of CVS.